Loading clinical trials...
Loading clinical trials...
Efficiency of the Novel Hepatitis B Vaccine Sci-B-Vac in HIV Positive Patients, a Prospective Cohort Study
Conditions
Interventions
Sci-B-Vac
Locations
1
Israel
Dan Turner
Tel Aviv, Israel
Start Date
November 1, 2011
Primary Completion Date
March 1, 2013
Completion Date
November 1, 2013
Last Updated
October 6, 2011
NCT07071623
NCT01875588
NCT04929028
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions